Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06278987

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.

Conditions

Interventions

TypeNameDescription
DRUGPENG block and cryoablationwill receive an ultrasound guided PENG block with 20 mL of 0.5% bupivacaine followed by cryoablation of the PENG nerves.
DRUGfascia iliaca compartment blockwill receive an ultrasound guided fascia iliaca compartment catheter with initial bolus of 20 mL of 0.5% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour

Timeline

Start date
2024-10-01
Primary completion
2026-10-01
Completion
2027-10-01
First posted
2024-02-26
Last updated
2025-11-25

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06278987. Inclusion in this directory is not an endorsement.

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture (NCT06278987) · Clinical Trials Directory